Galectin Therapeutics, Inc. (GALT)
4.20
+0.06
(+1.45%)
USD |
NASDAQ |
Sep 09, 13:07
Galectin Therapeutics Market Cap : 278.51M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 274.53M |
| September 04, 2026 | 305.70M |
| September 03, 2026 | 288.46M |
| September 02, 2026 | 297.08M |
| September 01, 2026 | 276.52M |
| August 31, 2026 | 261.93M |
| August 28, 2026 | 266.57M |
| August 27, 2026 | 274.53M |
| August 26, 2026 | 275.19M |
| August 25, 2026 | 264.58M |
| August 24, 2026 | 257.29M |
| August 21, 2026 | 244.03M |
| August 20, 2026 | 236.73M |
| August 19, 2026 | 243.36M |
| August 18, 2026 | 233.42M |
| August 17, 2026 | 232.75M |
| August 14, 2026 | 228.11M |
| August 13, 2026 | 234.08M |
| August 12, 2026 | 208.22M |
| August 11, 2026 | 207.56M |
| August 10, 2026 | 205.47M |
| August 07, 2026 | 227.21M |
| August 06, 2026 | 212.06M |
| August 05, 2026 | 203.50M |
| August 04, 2026 | 196.58M |
| Date | Value |
|---|---|
| August 03, 2026 | 199.55M |
| July 31, 2026 | 195.60M |
| July 30, 2026 | 212.72M |
| July 29, 2026 | 229.84M |
| July 28, 2026 | 223.25M |
| July 27, 2026 | 222.60M |
| July 24, 2026 | 228.52M |
| July 23, 2026 | 227.21M |
| July 22, 2026 | 230.50M |
| July 21, 2026 | 253.22M |
| July 20, 2026 | 263.43M |
| July 17, 2026 | 274.95M |
| July 16, 2026 | 278.25M |
| July 15, 2026 | 313.48M |
| July 14, 2026 | 351.68M |
| July 13, 2026 | 302.94M |
| July 10, 2026 | 267.38M |
| July 09, 2026 | 287.79M |
| July 08, 2026 | 297.01M |
| July 07, 2026 | 303.60M |
| July 06, 2026 | 304.92M |
| July 02, 2026 | 297.01M |
| July 01, 2026 | 285.16M |
| June 30, 2026 | 305.58M |
| June 29, 2026 | 327.31M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.785B |
| Alnylam Pharmaceuticals, Inc. | 34.14B |
| Anika Therapeutics, Inc. | 279.97M |
| Savara, Inc. | 1.108B |
| Vericel Corp. | 1.991B |
Market Cap Related Metrics
| Price | 4.20 |
| Earnings Yield | -10.23% |